Results 141 to 150 of about 20,148 (332)
Knowing the Knowing. Non-dual Meditative Practice From an Enactive Perspective. [PDF]
Front Psychol, 2022 Meling D.
europepmc +1 more source
Does Empowerment Maximisation Allow for Enactive Artificial Agents?
, 2016 Christian Guckelsberger, Christoph Salge
openalex +1 more source
Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients
British Journal of Clinical Pharmacology, EarlyView.Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel +12 more
wiley +1 more source
Zuranolone: A case study in (regulatory) rush to judgement?
British Journal of Clinical Pharmacology, EarlyView.Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
Enacting migration through data practices [PDF]
, 2019 Stephan Scheel +2 more
openalex +1 more source